Arkolith/Insider Trading/RNA/Form 4

Hughes Steven George

Chief Medical OfficerAvidity Biosciences, Inc. (RNA) · full profile →Form 4 · filed Jan 23, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$355K
Net Open-Market Flow
-$355K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jan 21, 2026Sell(S)2K$72.45$146K34K
Jan 21, 2026Sell(S)3K$72.45$209K32K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001599901-26-000026) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML